Induction of abnormal nuclear shapes in two distinct modes by overexpression of serine/threonine protein phosphatase 5 in HeLa cells

Journal of Cellular Biochemistry

Volumn 101, Issue 2, 2007, Pages 321-330

  Fukuda, Hirokazu ^a   Tsuchiya, Naoto ^a   Hara Fujita, Kaori ^a   Takagi, Sachiyo ^a   Nagao, Minako ^a   Nakagama, Hitoshi ^a,b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NONE   (Japan)

Author keywords

(E)GFP; Abnormal nuclei; Deformed nuclei; PP5; Protein phosphatase

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; MUTANT PROTEIN; PROTEIN; PROTEIN PHOSPHATASE 5; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE M PHASE; CELL NUCLEUS MEMBRANE; CELL SHAPE; CONTROLLED STUDY; HELA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; TRANSIENT EXPRESSION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE; CELL NUCLEUS; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASE; RATS; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT;

EID: 34247847746     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21178     Document Type: Article

References (33)

1. Ali A, Zang J, Bao S, Liu I, Otterness D, Dean NM, Abraham RT, Wang XF. 2004. Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. Genes Dev 18:249-254.
2. Beaudouin J, Gerlich D, Daigle N, Eils R, Ellenberg J. 2002. Nuclear envelope breakdown proceeds by microtubule-induced tearing of the lamina. Cell 108:83-96.
3. Becker W, Kentrup H, Klumpp S, Schultz JE, Joost HG. 1994. Molecular cloning of a protein serine/threonine phosphatase containing a putative regulatory tetratricopeptide repeat domain. J Biol Chem 269:22586-22592.
4. Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock W, Franklin R, McCubrey JA. 2003. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway. Int J Oncol 22:469-480.
5. Chen MX, Cohen PTW. 1997. Activation of protein phosphatase 5 by limited proteolysis or the binding of polyunsaturated fatty acids to the TPR domain. FEBS Lett 400:136-140.
6. Chen MX, McPartlin AE, Brown L, Chen YH, Barker HM, Cohen PT. 1994. A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus. EMBO J 13:4278-4290.
7. Chen MS, Silverstein AM, Pratt WB, Chinkers M. 1996. The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant. J Biol Chem 271:32315-32320.
8. Chinkers M. 1994. Targeting of a distinctive protein-serine phosphatase to the protein kinase-like domain of the atrial natriuretic peptide receptor. Proc Natl Acad Sci USA 91:11075-11079.
9. Chinkers M. 2001. Protein phosphatase 5 in signal transduction. Trends Endocrinol Metab 12:28-32.
10. Cohen PTW. 1997. Novel protein serine/threonine phosphatases: Variety is the spice of life. Trends Biochem Sci 22:245-251.
11. Egloff MP, Johnson DF, Moorhead G, Cohen PT, Cohen P, Barford D. 1997. Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1. EMBO J 16:1876-1887.
12. Fukuda H, Shima H, Vesonder RF, Tokuda H, Nishino H, Katoh S, Tamura S, Sugimura T, Nagao M. 1996. Inhibition of protein serine/threonine phosphatases by fumonisin B1, a mycotoxin. Biochem Biophys Res Commun 220:160-165.
13. Galingniana MD, Harrell JM, Murphy PJ, Chinkers M, Radanyi C, Renoir JM, Zang M, Pratt WB. 2002. Binding of hsp90-associated immunophilins to cytoplasmic dynein: Direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain. Biochemistry 41:13602-13610.
14. Gong CX, Liu F, Wu G, Rossie S, Wegiel J, Li L, Grundke-Iqbal I. 2004. Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5. J Neurochem 88:298-310.
15. Kang H, Sayner SL, Gross KL, Russell LC, Chinkers M. 2001. Identification of amino acids in the tetratricopeptide repeat and C-terminal domains of protein phosphatase 5 involved in autoinhibition and lipid activation. Biochemistry 40:10485-10490.
16. Lamb JR, Tugendreich S, Hieter P. 1995. Tetratrico peptide repeat interactions: To TPR or not to TPR? Trends Biochem Sci 20:257-259.
17. MacKintosh C, Moorhead G. 1993. Assay and purification of protein (serine/threonine) phosphatases. In: Hardie DG, editor. Protein phosphorylation: A practical approach. Oxford: Oxford Univ Press. pp 153-182.
18. Margalit A, Vlcek S, Gruenbaum Y, Foisner R. 2005. Breaking and making of the nuclear envelope. J Cell Biochem 95:454-465.
19. Morita K, Saitoh M, Tobiume K, Matsuura H, Enomoto S, Nishitoh H, Ichijo H. 2001. Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J 20:6028-6036.
20. Ollendorff V, Donoghue DJ. 1997. The serine/threonine phosphatase PP5 interacts with CDC16 and CDC27, two tetratricopeptide repeat-containing subunits of the anaphase-promoting complex. J Biol Chem 272:32011-32018.
21. Pines J. 2006. Mitosis: A matter of getting rid of the right protein at the right time. Trends Cell Biol 16:55-63.
22. Ramsey AJ, Chinkers M. 2002. Identification of potential physiological activators of protein phosphatase 5. Biochemistry 41:5625-5632.
23. Salina D, Bodoor K, Eckley DM, Schroer TA, Rattner JB, Burke B. 2002. Cytoplasmic dynein as a facilitator of nuclear envelope breakdown. Cell 108:97-107.
24. Sambrook J, Russel DW. 2001. Molecular cloning: A laboratory manual, 3rd edition. New York: Cold Spring Harbor Laboratory Press. pp 13.7-13.10.
25. Silverstein AM, Galigniana MD, Chen MS, Owens-Grillo JK, Chinkers M, Pratt WB. 1997. Protein phosphatase 5 is a major component of glucocorticoid receptor-hsp90 complexes with properties of an FK506-binding immunophilin. J Biol Chem 272:16224-16230.
26. Sinclair C, Borchers C, Parker C, Tomer K, Charbonneau H, Rossie S. 1999. The tetratricopeptide repeat domain and a C-terminal region control the activity of Ser/Thr protein phosphatase 5. J Biol Chem 274:23666-23672.
27. Skinner J, Sinclair C, Romeo C, Armstrong D, Charbonneau H, Rossie S. 1997. Purification of a fatty acid-stimulated protein-serine/threonine phosphatase from bovine brain and its identification as a homolog of protein phosphatase 5. J Biol Chem 272:22464-22471.
28. Steen RL, Collas P. 2001. Mistargeting of B-type lamins at the end of mitosis. Implication on cell survival and regulation of lamins a/c expression. J Cell Biol 153:621-626.
29. von Kriegsheim A, Pitt A, Grindlay GJ, Kolch W, Dhillon AS. 2006. Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5. Nat Cell Biol 8:1011-1016.
30. Yang J, Roel SM, Cliff MJ, Williams MA, Ladbury JE, Cohen PTW, Barford D. 2005. Molecular basis for TPR domain-mediated regulation of protein phosphatase 5. EMBO J 24:1-10.
31. Zeke T, Morrice N, Vázquez-Martin C, Cohen PTW. 2005. Human protein phosphatase 5 dissociates from heat-shock proteins and is proteolytically activated in response to arachidonic acid and the microtubule-depolymerizing drug nocodazole. Biochem J 385:45-56.
32. Zhang J, Bao S, Furumai R, Kucera KS, Ali A, Dean NM, Wang XF. 2005. Protein phosphatase 5 is required for ATR-mediated checkpoint activation. Mol Cell Biol 25:9910-9919.
33. Zuo Z, Dean NM, Honkanen RE. 1998. Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest. J Biol Chem 273:12250-12258.